keyword
MENU ▼
Read by QxMD icon Read
search

"Fibromyalgia"

keyword
https://www.readbyqxmd.com/read/30223011/brain-glial-activation-in-fibromyalgia-a-multi-site-positron-emission-tomography-investigation
#1
Daniel S Albrecht, Anton Forsberg, Angelica Sandstrom, Courtney Bergan, Diana Kadetoff, Ekaterina Protsenko, Jon Lampa, Yvonne C Lee, Caroline Olgart Höglund, Ciprian Catana, Simon Cervenka, Oluwaseun Akeju, Mats Lekander, George Cohen, Christer Halldin, Norman Taylor, Minhae Kim, Jacob M Hooker, Robert R Edwards, Vitaly Napadow, Eva Kosek, Marco L Loggia
Fibromyalgia (FM) is a poorly understood chronic condition characterized by widespread musculoskeletal pain, fatigue, and cognitive difficulties. While mounting evidence suggests a role for neuroinflammation, no study has directly provided evidence of brain glial activation in FM. In this study, we conducted a Positron Emission Tomography (PET) study using [11 C]PBR28, which binds to the translocator protein (TSPO), a protein upregulated in activated microglia and astrocytes. To enhance statistical power and generalizability, we combined datasets collected independently at two separate institutions (Massachusetts General Hospital [MGH] and Karolinska Institutet [KI])...
September 14, 2018: Brain, Behavior, and Immunity
https://www.readbyqxmd.com/read/30218052/ketamine-reduces-aversion-in-rodent-pain-models-by-suppressing-hyperactivity-of-the-anterior-cingulate-cortex
#2
Haocheng Zhou, Qiaosheng Zhang, Erik Martinez, Jahrane Dale, Sile Hu, Eric Zhang, Kevin Liu, Dong Huang, Guang Yang, Zhe Chen, Jing Wang
Chronic pain is known to induce an amplified aversive reaction to peripheral nociceptive inputs. This enhanced affective response constitutes a key pathologic feature of chronic pain syndromes such as fibromyalgia. However, the neural mechanisms that underlie this important aspect of pain processing remain poorly understood, hindering the development of treatments. Here, we show that a single dose of ketamine can produce a persistent reduction in the aversive response to noxious stimuli in rodent chronic pain models, long after the termination of its anti-nociceptive effects...
September 14, 2018: Nature Communications
https://www.readbyqxmd.com/read/30216492/oral-fluoroquinolones-and-risk-of-fibromyalgia
#3
Saeed Ganjizadeh-Zavareh, Mohit Sodhi, Tori Spangehl, Bruce Carleton, Mahyar Etminan
The Food and Drug Administration (FDA) has recently included a black box warning on fibromyalgia like symptoms with fluoroquinolones (FQs) but no large epidemiologic study is to date available. We undertook a case-control study using a random sample of 9,053,240 subjects obtained from the PharMetrics Plus health claims database in the United States. Cases received at least two fibromyalgia diagnoses coded by a rheumatologist matched to a ten randomly selected controls. After identifying 5,148 cases of fibromyalgia and 51,480 controls, the adjusted rate ratio of fibromyalgia for use of any fluoroquinolones, amoxicillin, and azithromycin were 1...
September 14, 2018: British Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/30212526/fibromyalgia-diagnosis-and-biased-assessment-sex-prevalence-and-bias
#4
Frederick Wolfe, Brian Walitt, Serge Perrot, Johannes J Rasker, Winfried Häuser
PURPOSE: Multiple clinical and epidemiological studies have provided estimates of fibromyalgia prevalence and sex ratio, but different criteria sets and methodology, as well as bias, have led to widely varying (0.4%->11%) estimates of prevalence and female predominance (>90% to <61%). In general, studies have failed to distinguish Criteria based fibromyalgia (CritFM) from Clinical fibromyalgia (ClinFM). In the current study we compare CritFM with ClinFM to investigate gender and other biases in the diagnosis of fibromyalgia...
2018: PloS One
https://www.readbyqxmd.com/read/30212264/fibromyalgia-is-it-a-neuropathic-pain
#5
Christina Wh Cheng, Clara Sm Wong, Grace Km Hui, Edmond Kn Chung, Steven Hs Wong
Fibromyalgia is a chronic pain syndrome of unclear pathophysiology. It is believed to be a dysfunction of the CNS, but no definite structural lesion has been identified so far. Despite a number of changes in the diagnostic criteria, diagnosis remains a clinical one. Since the 2011 revision of the IASP definition of neuropathic pain, fibromyalgia has been excluded from the diagnosis of neuropathic pain. More recent studies however found newer evidences of pathophysiology including small fiber neuropathy in patients with fibromyalgia...
September 13, 2018: Pain Management
https://www.readbyqxmd.com/read/30209437/intestinal-dysbiosis-and-hormonal-neuroendocrine-secretion-in-the-fibromyalgic-patient-relationship-and-correlations
#6
Giovanni Tomasello, Margherita Mazzola, Vincenzo Bosco, Giulia Tomasello, Provvidenza Damiani, Emanuele Sinagra, Francesco Carini
Fibromyalgia is a rheumatic syndrome and its pathogenesis is controversial. The recent literature has placed considerable attention on the link between alteration of the intestinal microbiota and fibromyalgia, emphasizing the close connection between the neuroenteric system and the CNS. This study aims to evaluate the probable relationship between intestinal dysbiosis and altered secretion of hormones and vitamins such as cortisol, serotonin, Vitamin D and thyroid hormones in a patient with fibromyalgia.
September 11, 2018: Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia
https://www.readbyqxmd.com/read/30198305/milnacipran-serotonin-noradrenaline-reuptake-inhibitor-approved-for-fibromyalgia-may-be-a-useful-antidepressant
#7
Nicholas A Keks, Judy Hope, Simone Keogh, David L Copolov
OBJECTIVE: Milnacipran is a serotonin noradrenaline reuptake inhibitor (SNRI) approved for treatment of fibromyalgia in Australia, but is used for depression in Europe and elsewhere. This paper will briefly review milnacipran and its utility in psychiatry for the treatment of depression. CONCLUSION: Milnacipran is a dual reuptake inhibitor of noradrenaline and serotonin, with greater effect on noradrenaline than serotonin, in contrast to the related drugs venlafaxine, desvenlafaxine and duloxetine...
September 10, 2018: Australasian Psychiatry: Bulletin of Royal Australian and New Zealand College of Psychiatrists
https://www.readbyqxmd.com/read/30194544/other-antidepressants
#8
T E Schwasinger-Schmidt, M Macaluso
This chapter addresses the following FDA-approved medications for the treatment of major depressive disorder available for use in the United States including bupropion, mirtazapine, trazodone, vortioxetine, and vilazodone. These medications do not belong to one of the previously featured classes of antidepressants discussed in the preceding chapters. Each medication featured in this chapter has a unique structure and properties that target diverse receptors in the central nervous system. These diverse targets are distinct from other classes of medications used to treat major depressive disorder...
September 8, 2018: Handbook of Experimental Pharmacology
https://www.readbyqxmd.com/read/30194498/computer-assisted-cognitive-behavior-therapy-in-medical-care-settings
#9
REVIEW
Jesse H Wright, Laura W McCray, Tracy D Eells, Rangaraj Gopalraj, Laura B Bishop
PURPOSE OF REVIEW: We reviewed research on computer-assisted cognitive-behavior therapy (CCBT) performed in medical settings with the goals of assessing the effectiveness of this newer method of treatment delivery, evaluating the need for clinician support of therapeutic computer programs, and making suggestions for future research and clinical implementation. RECENT FINDINGS: The overall results of randomized, controlled trials suggest that CCBT can be an effective treatment for depression in primary care patients and health care anxiety...
September 7, 2018: Current Psychiatry Reports
https://www.readbyqxmd.com/read/30193908/microfluidic-devices-for-disease-modeling-in-muscle-tissue
#10
Mollie M Smoak, Hannah A Pearce, Antonios G Mikos
Microfluidic devices have advanced significantly in recent years and are a promising technology for the field of tissue engineering. Highly sophisticated microfabrication techniques have paved the way for the development of complex ex vivo models capable of incorporating and measuring the real-time response of multiple cell types interacting together in a single system. Muscle-on-a-chip technology has drastically improved and serves as a drug screening platform for many muscular diseases such as muscular dystrophy, tendinosis, fibromyalgia, mitochondrial myopathy, and myasthenia gravis...
August 30, 2018: Biomaterials
https://www.readbyqxmd.com/read/30192068/outpatient-engagement-lowers-predicted-risk-of-suicide-attempts-in-fibromyalgia
#11
Lindsey C McKernan, Matthew C Lenert, Leslie J Crofford, Colin G Walsh
OBJECTIVE: Fibromyalgia (FM) patients are 10x more likely to die by suicide than the general population. The purpose of this study was to externally validate published models predicting suicidal ideation and attempts in FM and identify interpretable risk and protective factors for suicidality unique to FM. METHODS: This is a case-control study of large-scale EHR data collected from 1998-2017, identifying FM cases with validated PheKB criteria. Model performance was measured through discrimination including area under the receiver operating characteristic (AUC), sensitivity, specificity, and through calibration including calibration plots...
September 7, 2018: Arthritis Care & Research
https://www.readbyqxmd.com/read/30189347/opioid-receptors-in-the-gi-tract-targets-for-treatment-of-both-diarrhea-and-constipation-in-functional-bowel-disorders
#12
REVIEW
J Pannemans, M Corsetti
Opioids have been used for centuries, mostly as a sedative and to treat pain. Currently, they are used on a global scale for the treatment of acute and chronic pain in diseases as osteoarthritis, fibromyalgia, and low back pain. Binding of opioids on opioid receptors can cause a range of different effects such as changes in stress response, analgesia, motor activity and autonomic functions. This review provide a synthetic summary of the most recent literature on the use of drugs acting on mu-receptors to treat two prevalent functional bowel disorders, presenting with opposite bowel habit...
September 3, 2018: Current Opinion in Pharmacology
https://www.readbyqxmd.com/read/30189165/-analysis-of-the-cochrane-review-pregabalin-for-pain-in-fibromyalgia-in-adults-cochrane-database-syst-rev-2016-9-cd011790-and-2016-4-cd009002
#13
Guilherme Ferreira-Dos-Santos, David Cordeiro Sousa, João Costa, António Vaz-Carneiro
Fibromyalgia can be clinically defined by widespread pain lasting for longer than 3 months with tenderness on palpation in 11 or more of 18 specified tender points. Many people with fibromyalgia are significantly disabled, and experience moderate to severe pain for many years, for which conventional analgesics are usually not effective. For these patients treatment options generally include antidepressants like tricyclic agents, serotonin and noradrenaline reuptake inhibitors, or anticonvulsants like pregabalin or gabapentin...
August 31, 2018: Acta Médica Portuguesa
https://www.readbyqxmd.com/read/30185358/evidence-of-peripheral-large-nerve-involvement-in-fibromyalgia-a-retrospective-review-of-emg-and-nerve-conduction-findings-in-55-fm-subjects
#14
Xavier J Caro, Robert G Galbraith, Earl F Winter
OBJECTIVE: Whereas small fiber neuropathy (SFN) is now a recognized part of fibromyalgia (FM), surprisingly little attention has been paid to any findings of large fiber neuropathy (LFN) in this disorder. Since 90% to 95% of FM subjects seen in our outpatient facility routinely undergo EMG and nerve conduction studies (NCS) we elected to retrospectively review the EMG/NCS results garnered from a large cohort of unselected subjects in order to describe the electrodiagnostic features of LFN in FM...
July 2018: European Journal of Rheumatology
https://www.readbyqxmd.com/read/30183596/epidemiological-pharmacological-and-sociodemographic-characterisation-of-a-population-of-386-fibromyalgic-patients-referred-to-a-tertiary-pain-centre-in-italy
#15
Alvise Martini, Vittorio Schweiger, Giovanna Del Balzo, Giulia Sartori, Massimo Parolini, Eris Chinellato, Piercarlo Sarzi-Puttini, Enrico Polati
Fibromyalgia's prevalence in Italy is about 4%. Apart from widespread pain and the three main conditions related to fibromyalgia that are included in its diagnosis (fatigue, unrefreshing sleep and cognitive disorders disturbances), there are a number of minor symptoms that have been associated to fibromyalgia. The current study aimed to characterise fibromyalgic patients referring to a single tertiary pain centre not only for sociodemographic data, but also with special attention on pharmacological history and "minor" symptoms...
August 29, 2018: Clinical and Experimental Rheumatology
https://www.readbyqxmd.com/read/30182012/auricular-acupuncture-for-craving-in-a-single-subject-case-study-of-woman-with-fibromyalgia-and-chronic-ecstasy-use
#16
Bijan Pirnia, Kambiz Pirnia, Alireza Zahiroddin
No abstract text is available yet for this article.
July 2018: Iranian Journal of Public Health
https://www.readbyqxmd.com/read/30181753/serum-levels-of-serotonin-as-a-biomarker-of-newly-diagnosed-fibromyalgia-in-women-its-relation-to-the-platelet-indices
#17
Marwan S M Al-Nimer, Talar A Merza Mohammad, Riyadh A Alsakeni
Background: This study aimed to assess the serum serotonin levels in the newly diagnosed fibromyalgia (FM) and to relate these levels to the presenting signs and symptoms. Materials and Methods: This case-control study included 35 healthy women (Group I) served as controls and 130 women with newly diagnosed FM (Group II). The diagnosis of FM was confirmed by the diagnostic criteria of the American College of Rheumatology-10. The assessment of pain using a revised fibromyalgia impact questionnaire and tender points scoring, blood platelet indices, and serum serotonin levels were determined...
2018: Journal of Research in Medical Sciences: the Official Journal of Isfahan University of Medical Sciences
https://www.readbyqxmd.com/read/30178880/headache-attributed-to-tmd-is-associated-with-the-presence-of-comorbid-bodily-pain-a-case-control-study
#18
Daniela Vivaldi, Massimiliano Di Giosia, Inna E Tchivileva, Gary W Jay, Gary D Slade, Pei F Lim
Headache attributed to temporomandibular disorders (TMDH) is defined as a secondary headache by the International Classification of Headache Disorders 3rd edition (ICHD-3). OBJECTIVE: The objective of this case-control study is to investigate the phenotypic characteristics of chronic TMD with and without TMDH. We hypothesize that chronic TMD with TMDH is associated with increased number of bodily pain conditions, more painful sites in the head and neck region, and greater TMD pain intensity...
September 4, 2018: Headache
https://www.readbyqxmd.com/read/30178511/distribution-of-rheumatological-diseases-in-rural-and-urban-areas-an-adapted-copcord-stage-i-phase-iii-survey-of-lucknow-district-in-north-india
#19
Puneet Kumar, Ragini Alok, Siddharth K Das, Ragini Srivastava, Girdhar G Agarwal
OBJECTIVES: To study the distribution of various rheumatological diseases in rural and urban areas of Lucknow, India. METHOD: A study using adapted a Community Oriented Program for the Control of Rheumatic Diseases scheme was carried out in a cluster of rural (n = 5118) and urban (n = 5053) communities through a door-to-door survey. Trained community volunteers completed the questionnaires. Patients with musculoskeletal pain (MSK pain) were clinically evaluated by a physician...
September 4, 2018: International Journal of Rheumatic Diseases
https://www.readbyqxmd.com/read/30176973/gray-matter-changes-following-cognitive-behavioral-therapy-for-patients-with-comorbid-fibromyalgia-and-insomnia-a-pilot-study
#20
Christina S McCrae, Jennifer M Mundt, Ashley F Curtis, Jason G Craggs, Andrew M O'Shea, Roland Staud, Richard B Berry, William M Perlstein, Michael E Robinson
STUDY OBJECTIVES: Insomnia frequently co-occurs with fibromyalgia, which is associated with gray matter atrophy. We examined the effect of cognitive behavioral therapy for insomnia (CBT-I) and pain (CBT-P) on cortical thickness. METHODS: Patients with fibromyalgia and insomnia underwent MRI before and after random assignment to CBT-I (n = 14), CBT-P (n = 16), or waitlist control (WLC; n = 7). RESULTS: Repeated-measures analyses of variance revealed significant interactions for two (left lateral orbitofrontal cortex, left rostral middle frontal, P s < ...
August 30, 2018: Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine
keyword
keyword
110366
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"